APA (7th ed.) Citation

AH, S., RM, L., RN, M., AN, K., DM, A., AM, C., . . . CA, S. (2026). Ceftriaxone Versus Piperacillin-Tazobactam Monotherapy for Open Fracture Prophylaxis: A Retrospective Cohort Study. Journal of orthopaedic trauma, 40(6), 294. https://doi.org/10.1097/BOT.0000000000003153

Chicago Style (17th ed.) Citation

AH, Sisson, Litten RM, McIlwain RN, Kimbel AN, Alcaide DM, Cimino AM, Johnson JP, and Spitler CA. "Ceftriaxone Versus Piperacillin-Tazobactam Monotherapy for Open Fracture Prophylaxis: A Retrospective Cohort Study." Journal of Orthopaedic Trauma 40, no. 6 (2026): 294. https://doi.org/10.1097/BOT.0000000000003153.

MLA (9th ed.) Citation

AH, Sisson, et al. "Ceftriaxone Versus Piperacillin-Tazobactam Monotherapy for Open Fracture Prophylaxis: A Retrospective Cohort Study." Journal of Orthopaedic Trauma, vol. 40, no. 6, 2026, p. 294, https://doi.org/10.1097/BOT.0000000000003153.